| Targeting folate receptor alpha for cancer treatment A Cheung, HJ Bax, DH Josephs, KM Ilieva, G Pellizzari, J Opzoomer, ... Oncotarget 7 (32), 52553, 2016 | 425 | 2016 |
| Combining immune checkpoint inhibitors: established and emerging targets and strategies to improve outcomes in melanoma DO Khair, HJ Bax, S Mele, S Crescioli, G Pellizzari, A Khiabany, ... Frontiers in immunology 10, 453, 2019 | 224 | 2019 |
| A tool kit for rapid cloning and expression of recombinant antibodies TS Dodev, P Karagiannis, AE Gilbert, DH Josephs, H Bowen, LK James, ... Scientific reports 4 (1), 5885, 2014 | 113 | 2014 |
| IgE antibodies: from structure to function and clinical translation BJ Sutton, AM Davies, HJ Bax, SN Karagiannis Antibodies 8 (1), 19, 2019 | 110 | 2019 |
| Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action ZN Willsmore, BGT Coumbe, S Crescioli, S Reci, A Gupta, RJ Harris, ... European Journal of Immunology 51 (3), 544-556, 2021 | 103 | 2021 |
| BRAF inhibitors: resistance and the promise of combination treatments for melanoma M Griffin, D Scotto, DH Josephs, S Mele, S Crescioli, HJ Bax, G Pellizzari, ... Oncotarget 8 (44), 78174, 2017 | 103 | 2017 |
| Cytokinergic IgE action in mast cell activation HJ Bax, AH Keeble, HJ Gould Frontiers in Immunology 3, 229, 2012 | 89 | 2012 |
| AllergoOncology–the impact of allergy in oncology: EAACI position paper E Jensen‐Jarolim, HJ Bax, R Bianchini, M Capron, C Corrigan, M Castells, ... Allergy 72 (6), 866-887, 2017 | 85 | 2017 |
| Tumour-associated macrophage polarisation and re-education with immunotherapy DH Josephs, HJ Bax, SN Karagiannis Front Biosci (Elite Ed) 7 (2), 293-308, 2015 | 79 | 2015 |
| Anti-folate receptor alpha–directed antibody therapies restrict the growth of triple-negative breast cancer A Cheung, J Opzoomer, KM Ilieva, P Gazinska, RM Hoffmann, H Mirza, ... Clinical Cancer Research 24 (20), 5098-5111, 2018 | 78 | 2018 |
| Anti-folate receptor-α IgE but not IgG recruits macrophages to attack tumors via TNFα/MCP-1 signaling DH Josephs, HJ Bax, T Dodev, M Georgouli, M Nakamura, G Pellizzari, ... Cancer research 77 (5), 1127-1141, 2017 | 73 | 2017 |
| Inhibition of allergen‐dependent IgE activity by antibodies of the same specificity but different class TS Dodev, H Bowen, MH Shamji, HJ Bax, AJ Beavil, JM McDonnell, ... Allergy 70 (6), 720-724, 2015 | 67 | 2015 |
| AllergoOncology: opposite outcomes of immune tolerance in allergy and cancer E Jensen‐Jarolim, HJ Bax, R Bianchini, S Crescioli, TR Daniels‐Wells, ... Allergy 73 (2), 328-340, 2018 | 62 | 2018 |
| IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin L Saul, KM Ilieva, HJ Bax, P Karagiannis, I Correa, ... Scientific reports 6 (1), 29736, 2016 | 61 | 2016 |
| Beta-glucan contamination of pharmaceutical products: How much should we accept? C Barton, K Vigor, R Scott, P Jones, H Lentfer, HJ Bax, DH Josephs, ... Cancer immunology, immunotherapy 65, 1289-1301, 2016 | 57 | 2016 |
| IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states G Pellizzari, C Hoskin, S Crescioli, S Mele, J Gotovina, G Chiaruttini, ... EBioMedicine 43, 67-81, 2019 | 56 | 2019 |
| B cells in patients with melanoma: implications for treatment with checkpoint inhibitor antibodies ZN Willsmore, RJ Harris, S Crescioli, K Hussein, H Kakkassery, D Thapa, ... Frontiers in Immunology 11, 622442, 2021 | 54 | 2021 |
| Characterization of selective calcium-release activated calcium channel blockers in mast cells and T-cells from human, rat, mouse and guinea-pig preparations LV Rice, HJ Bax, LJ Russell, VJ Barrett, SE Walton, AM Deakin, ... European journal of pharmacology 704 (1-3), 49-57, 2013 | 52 | 2013 |
| AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI) D Ferastraoaru, HJ Bax, C Bergmann, M Capron, M Castells, ... Clinical and translational allergy 10 (1), 32, 2020 | 49 | 2020 |
| Therapeutic IgE antibodies: harnessing a macrophage-mediated immune surveillance mechanism against cancer SN Karagiannis, DH Josephs, HJ Bax, JF Spicer Cancer Research 77 (11), 2779-2783, 2017 | 43 | 2017 |
